Avecho Biotechnology Ltd (AVE) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.026x

Based on the latest financial reports, Avecho Biotechnology Ltd (AVE) has a cash flow conversion efficiency ratio of -0.026x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-49.47K ≈ $-35.00K USD) by net assets (AU$1.91 Million ≈ $1.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Avecho Biotechnology Ltd for the company's overall valuation and market capitalisation.

Avecho Biotechnology Ltd - Cash Flow Conversion Efficiency Trend (1993–2025)

This chart illustrates how Avecho Biotechnology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Avecho Biotechnology Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Avecho Biotechnology Ltd ranked by their cash flow conversion efficiency. Explore AVE cash flow quality score to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Y/KNOT S.A.
AT:YKNOT
N/A
Byuksan Corp
KO:007210
0.029x
Sukhjit Starch & Chemicals Limited
NSE:SUKHJITS
-0.146x
Chips&Media Inc
KQ:094360
0.065x
High Roller Technologies, Inc.
NYSE MKT:ROLR
-0.012x
Mistral Gayrimenkul Yatirim Ortakligi AS
IS:MSGYO
-0.005x
Big Sunshine Co Ltd
TW:1475
0.037x
Pollux Properti Indonesia Tbk PT
JK:POLL
-0.007x

Annual Cash Flow Conversion Efficiency for Avecho Biotechnology Ltd (1993–2025)

The table below shows the annual cash flow conversion efficiency of Avecho Biotechnology Ltd from 1993 to 2025. View AVE stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 AU$1.56 Million
≈ $1.10 Million
AU$1.10 Million
≈ $780.51K
0.707x +158.27%
2024-12-31 AU$3.27 Million
≈ $2.31 Million
AU$-3.97 Million
≈ $-2.81 Million
-1.214x -143.44%
2023-12-31 AU$6.38 Million
≈ $4.51 Million
AU$-3.18 Million
≈ $-2.25 Million
-0.499x +27.39%
2022-12-31 AU$2.42 Million
≈ $1.72 Million
AU$-1.67 Million
≈ $-1.18 Million
-0.687x -0.54%
2021-12-31 AU$4.54 Million
≈ $3.21 Million
AU$-3.10 Million
≈ $-2.19 Million
-0.683x -27.40%
2020-12-31 AU$2.65 Million
≈ $1.88 Million
AU$-1.42 Million
≈ $-1.01 Million
-0.536x -314.63%
2019-12-31 AU$4.76 Million
≈ $3.37 Million
AU$1.19 Million
≈ $841.16K
0.250x +144.53%
2018-12-31 AU$3.90 Million
≈ $2.76 Million
AU$-2.19 Million
≈ $-1.55 Million
-0.561x +44.06%
2017-12-31 AU$6.40 Million
≈ $4.53 Million
AU$-6.42 Million
≈ $-4.54 Million
-1.003x -82.12%
2016-12-31 AU$11.65 Million
≈ $8.24 Million
AU$-6.41 Million
≈ $-4.54 Million
-0.551x -82.97%
2015-12-31 AU$28.93 Million
≈ $20.47 Million
AU$-8.71 Million
≈ $-6.16 Million
-0.301x -118.93%
2014-12-31 AU$49.03 Million
≈ $34.69 Million
AU$-6.74 Million
≈ $-4.77 Million
-0.137x +34.67%
2013-12-31 AU$40.77 Million
≈ $28.85 Million
AU$-8.58 Million
≈ $-6.07 Million
-0.210x -12.95%
2012-12-31 AU$62.61 Million
≈ $44.30 Million
AU$-11.66 Million
≈ $-8.25 Million
-0.186x -46.22%
2011-12-31 AU$72.95 Million
≈ $51.61 Million
AU$-9.29 Million
≈ $-6.58 Million
-0.127x +40.42%
2010-12-31 AU$39.01 Million
≈ $27.60 Million
AU$-8.34 Million
≈ $-5.90 Million
-0.214x -19.25%
2009-12-31 AU$49.99 Million
≈ $35.37 Million
AU$-8.96 Million
≈ $-6.34 Million
-0.179x -27.81%
2008-12-31 AU$51.55 Million
≈ $36.48 Million
AU$-7.23 Million
≈ $-5.12 Million
-0.140x -72.82%
2007-12-31 AU$133.76 Million
≈ $94.65 Million
AU$-10.86 Million
≈ $-7.68 Million
-0.081x -35.51%
2006-12-31 AU$135.47 Million
≈ $95.86 Million
AU$-8.12 Million
≈ $-5.74 Million
-0.060x -73.92%
2005-12-31 AU$132.14 Million
≈ $93.50 Million
AU$-4.55 Million
≈ $-3.22 Million
-0.034x -187.04%
2004-12-31 AU$113.22 Million
≈ $80.11 Million
AU$-1.36 Million
≈ $-961.27K
-0.012x +57.60%
2003-12-31 AU$29.38 Million
≈ $20.79 Million
AU$-831.60K
≈ $-588.41K
-0.028x +53.36%
2002-12-31 AU$14.81 Million
≈ $10.48 Million
AU$-898.56K
≈ $-635.79K
-0.061x -18.47%
2001-12-31 AU$18.34 Million
≈ $12.98 Million
AU$-939.40K
≈ $-664.68K
-0.051x -29.20%
2000-12-31 AU$20.67 Million
≈ $14.63 Million
AU$-819.60K
≈ $-579.92K
-0.040x +41.04%
1999-12-31 AU$5.02 Million
≈ $3.55 Million
AU$-337.79K
≈ $-239.01K
-0.067x +73.74%
1998-12-31 AU$1.59 Million
≈ $1.12 Million
AU$-406.45K
≈ $-287.59K
-0.256x +63.11%
1997-12-31 AU$5.45 Million
≈ $3.86 Million
AU$-3.78 Million
≈ $-2.68 Million
-0.694x -540.59%
1996-12-31 AU$27.18 Million
≈ $19.23 Million
AU$-2.94 Million
≈ $-2.08 Million
-0.108x -118.58%
1995-12-31 AU$28.90 Million
≈ $20.45 Million
AU$-1.43 Million
≈ $-1.01 Million
-0.050x +56.02%
1994-12-31 AU$10.81 Million
≈ $7.65 Million
AU$-1.22 Million
≈ $-862.52K
-0.113x -5205.41%
1993-12-31 AU$10.42 Million
≈ $7.37 Million
AU$23.00K
≈ $16.27K
0.002x --

About Avecho Biotechnology Ltd

AU:AVE Australia Biotechnology
Market Cap
$54.68 Million
AU$77.27 Million AUD
Market Cap Rank
#21673 Global
#752 in Australia
Share Price
AU$0.02
Change (1 day)
-4.76%
52-Week Range
AU$0.01 - AU$0.03
All Time High
AU$0.04
About

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic f… Read more